Read the latest experimental hematology articles on ScienceDirect.com, Elsevier's leading platform for peer-reviewed scientific literature. Review published on: 23. Full text. PDF. Novel Agents and Regimens in the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma: Latest Updates, Anniversary Review Series, Review Articles, Free Access to Highlighted Articles, Special Issues Metabolic Control in Hematopoietic Homeostasis Genomics and , Anniversary Journal Series, Review Articles, Free Access to Highlighted Articles, Special Issues Metabolic Control in Hematopoietic Homeostasis Genomics and, Explore the latest full-text research PDFs, articles, conference papers, preprints and more at EXPERIMENTAL HEMATOLOGY. Find methods information, explore the latest full-text research PDFs, articles, conference papers, preprints and more on EXPERIMENTAL HEMATOLOGY. Find information on methods, sources, references or conduct a literature review. Cellular immunotherapy, particularly CAR-T cells, has shown potential in improving outcomes in patients with refractory and recurrent blood malignancies. However, achieving long-term complete and durable remission from blood cancer remains a challenge, with resistance and relapse being expected outcomes for many. The LCL mimetic SMAC targets JAK mutant cells. Brianna M. Craver. Thanh Kim Nguyen. Angela G. Fleischman. Research. Free access. Published: 02. Article: 1. list of articles on experimental hematology and oncology. State Key Laboratory of Experimental Hematology and National Clinical Research Center of Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Beijing Union Medical College. Single-cell transcriptomic landscape of human blood cells, National Science Review; Hematology Reviews is an international, peer-reviewed, open access journal on all aspects of the prevention, diagnosis and management of blood disorders, published semi-annually online by Voghera PV Medit. Note that as of 2010, Hematology Reviews was renamed Hematology Reports. Open access, experimental hematology and oncology. Volumes and numbers. Search the newspaper. Research. in this problem. Content Type: Open Access Journal Published: 28, Article: 99 Unique VHH-driven BCMA CAR-NK cells for multiple myeloma. Immunotherapy has become the central pillar of cancer treatment. ICI immune checkpoint inhibitors, a major category of tumor immunotherapy, reactivate pre-existing anticancer immunity. Initially, ICIs were only approved for advanced and metastatic cancers in the salvage setting after or concurrently with chemotherapy,